665 related articles for article (PubMed ID: 26143402)
1. Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective study.
Amsterdam JD; Lorenzo-Luaces L; Soeller I; Li SQ; Mao JJ; DeRubeis RJ
J Affect Disord; 2015 Oct; 185():31-7. PubMed ID: 26143402
[TBL] [Abstract][Full Text] [Related]
2. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
Amsterdam JD; Wang CH; Shwarz M; Shults J
J Affect Disord; 2009 Jan; 112(1-3):219-30. PubMed ID: 18486235
[TBL] [Abstract][Full Text] [Related]
3. Short-term venlafaxine v. lithium monotherapy for bipolar type II major depressive episodes: effectiveness and mood conversion rate.
Amsterdam JD; Lorenzo-Luaces L; Soeller I; Li SQ; Mao JJ; DeRubeis RJ
Br J Psychiatry; 2016 Apr; 208(4):359-65. PubMed ID: 26892848
[TBL] [Abstract][Full Text] [Related]
4. Rapid versus non-rapid cycling bipolar II depression: response to venlafaxine and lithium and hypomanic risk.
Lorenzo-Luaces L; Amsterdam JD; Soeller I; DeRubeis RJ
Acta Psychiatr Scand; 2016 Jun; 133(6):459-69. PubMed ID: 26803764
[TBL] [Abstract][Full Text] [Related]
5. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
Amsterdam JD; Shults J
J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study.
Amsterdam JD; Shults J
Am J Psychiatry; 2010 Jul; 167(7):792-800. PubMed ID: 20360317
[TBL] [Abstract][Full Text] [Related]
7. Residual anxiety may be associated with depressive relapse during continuation therapy of bipolar II depression.
Lorenzo-Luaces L; Amsterdam JD; DeRubeis RJ
J Affect Disord; 2018 Feb; 227():379-383. PubMed ID: 29149756
[TBL] [Abstract][Full Text] [Related]
8. Effects of venlafaxine versus lithium monotherapy on quality of life in bipolar II major depressive disorder: Findings from a double-blind randomized controlled trial.
Lorenzo-Luaces L; Amsterdam JD
Psychiatry Res; 2018 Jan; 259():455-459. PubMed ID: 29136600
[TBL] [Abstract][Full Text] [Related]
9. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.
Leverich GS; Altshuler LL; Frye MA; Suppes T; McElroy SL; Keck PE; Kupka RW; Denicoff KD; Nolen WA; Grunze H; Martinez MI; Post RM
Am J Psychiatry; 2006 Feb; 163(2):232-9. PubMed ID: 16449476
[TBL] [Abstract][Full Text] [Related]
10. Step-wise loss of antidepressant effectiveness with repeated antidepressant trials in bipolar II depression.
Amsterdam JD; Lorenzo-Luaces L; DeRubeis RJ
Bipolar Disord; 2016 Nov; 18(7):563-570. PubMed ID: 27805299
[TBL] [Abstract][Full Text] [Related]
11. Multi-trial, aggregated, individual participant data mega-analysis of short-term antidepressant versus mood stabilizer monotherapy of bipolar type II major depressive episode.
Amsterdam JD; Xu C
Bipolar Disord; 2024 May; 26(3):255-264. PubMed ID: 37749069
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and mood conversion rate during long-term fluoxetine v. lithium monotherapy in rapid- and non-rapid-cycling bipolar II disorder.
Amsterdam JD; Luo L; Shults J
Br J Psychiatry; 2013 Apr; 202(4):301-6. PubMed ID: 23099447
[TBL] [Abstract][Full Text] [Related]
13. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
Tohen M; Greil W; Calabrese JR; Sachs GS; Yatham LN; Oerlinghausen BM; Koukopoulos A; Cassano GB; Grunze H; Licht RW; Dell'Osso L; Evans AR; Risser R; Baker RW; Crane H; Dossenbach MR; Bowden CL
Am J Psychiatry; 2005 Jul; 162(7):1281-90. PubMed ID: 15994710
[TBL] [Abstract][Full Text] [Related]
14. The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample.
Oedegaard KJ; Alda M; Anand A; Andreassen OA; Balaraman Y; Berrettini WH; Bhattacharjee A; Brennand KJ; Burdick KE; Calabrese JR; Calkin CV; Claasen A; Coryell WH; Craig D; DeModena A; Frye M; Gage FH; Gao K; Garnham J; Gershon E; Jakobsen P; Leckband SG; McCarthy MJ; McInnis MG; Maihofer AX; Mertens J; Morken G; Nievergelt CM; Nurnberger J; Pham S; Schoeyen H; Shekhtman T; Shilling PD; Szelinger S; Tarwater B; Yao J; Zandi PP; Kelsoe JR
BMC Psychiatry; 2016 May; 16():129. PubMed ID: 27150464
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety.
Ghaemi SN; Ostacher MM; El-Mallakh RS; Borrelli D; Baldassano CF; Kelley ME; Filkowski MM; Hennen J; Sachs GS; Goodwin FK; Baldessarini RJ
J Clin Psychiatry; 2010 Apr; 71(4):372-80. PubMed ID: 20409444
[TBL] [Abstract][Full Text] [Related]
16. Comparison of treatment outcome using two definitions of rapid cycling in subjects with bipolar II disorder.
Amsterdam JD; Lorenzo-Luaces L; DeRubeis RJ
Bipolar Disord; 2017 Feb; 19(1):6-12. PubMed ID: 28160351
[TBL] [Abstract][Full Text] [Related]
17. The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: a retrospective chart review.
Altshuler L; Kiriakos L; Calcagno J; Goodman R; Gitlin M; Frye M; Mintz J
J Clin Psychiatry; 2001 Aug; 62(8):612-6. PubMed ID: 11561933
[TBL] [Abstract][Full Text] [Related]
18. Fluoxetine monotherapy of bipolar type II and bipolar NOS major depression: a double-blind, placebo-substitution, continuation study.
Amsterdam JD; Shults J
Int Clin Psychopharmacol; 2005 Sep; 20(5):257-64. PubMed ID: 16096516
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).
Young AH; McElroy SL; Bauer M; Philips N; Chang W; Olausson B; Paulsson B; Brecher M;
J Clin Psychiatry; 2010 Feb; 71(2):150-62. PubMed ID: 20122369
[TBL] [Abstract][Full Text] [Related]
20. Prior Antidepressant Treatment Trials May Predict a Greater Risk of Depressive Relapse During Antidepressant Maintenance Therapy.
Amsterdam JD; Kim TT
J Clin Psychopharmacol; 2019; 39(4):344-350. PubMed ID: 31205190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
